Year 2023 Vol. 31 No 3

SCIENTIFIC PUBLICATIONS

Y.I. GALITSKAYA 1, S.L. ACHINOVICH 2, Z.A. DUNDAROV 3, D.A. EVSEENKO 3

CLINICAL AND MORPHOLOGIC CRITERIA OF SCARRING SKIN CHANGES

State Institution RSPC for Radiation Medicine and Human Ecology MH RB 1,
Gomel Regional Clinical Oncologic Dispensary MH RB 2,
Educational Institution Gomel State Medical Universities, MH RB 3, Gomel,
Republic of Belarus

Objective. The research has focused on objectively defining scar criteria and outcomes. It is to provide information about current clinical and morphologic criteria of skin scarring changes to determine promising techniques of treatment, rehabilitation of patients with pathologic scarring.
Methods. The developed system allows analyzing the number of the publications and the citations by years, by keywords, by authors, by scientific sections, etc. in electronic bibliographic databases PubMed, eLibrary, Web of science, Cyberleninca, Cochrane Library over the period 2013 2023 yrs.
Results. For a review of the scientific literature 260 sources have been studied and 42 publications have been included in it. Over the last decade the use of domestic and foreign core data for comparative research ensures the comprehensiveness of the study. It has shown that rehabilitation of patients with scar deformities is considered as an actual problem of reconstructive surgery and as a socially significant issue requiring the involvement of high-tech diagnostic methods with the subsequent combined pathogenetic treatment.
Conclusion. The most important aim for scar treatment is the improvement of functional and aesthetical deformities. Studies to determine some pathohistological parameters, including the assessment of epithelial-mesenchymal transformation of scar deformities and clinical manifestations, provides the basis for building a new effective techniques of treatment.

Keywords: skin scarring, morphology, epithelial-mesenchymal transition, combined treatment
p. 220-230 of the original issue
References
  1. Belousov AE. Rubtsy i ikh korrektsiia. Ocherki plasticheskoi khirurgii. Sankt-Petersburg, RF: KOMANDOR-SPB; 2005. T 1. 128p. (In Russ.)
  2. Alekseeva NT, Nikitjuk DB, Klochkova SV. Analiticheskaja morfologija reparativnoj regeneracii v kozhe pod dejstviem razlichnyh regionalnyh faktorov. Zhurn Anatomii i Gistopatologii. 2015;4(1(13):26-37. . (In Russ.)
  3. Galickaja JuI, Dundarov ZA, Evseenko DA, Adamovich DM. Analiz vozmozhnostej i perspektiv metoda lipofilinga u pacientov s atroficheskimi rubcovymi izmenenijami kozhi: obzor literatury. Hirurgija. Vostochnaja Evropa. 2023;12(2):177-85. . (In Russ.)
  4. . Filippova OV, Afonichev KA, Krasnogorskij IN, Vashetko RV Clinical and morphological features of the vascular bed of hypertrophic scar tissue at different times of its formation Ortopedija, Travmatologija i Vosstanovitelnaja Hirurgija Detskogo Vozrasta. 2017;5(3):25-36. doi: 10.17816/PTORS5325-36(In Russ.)
  5. Obraztsova AE, Nozdrevatykh AA. Morphofunctional features of the repair process in healing of skin wounds taking into account possible scar deformations (literature review) Vestn Novyh Med Tehnologij [Jelektronnoe izd.]. 2021;(1). Publ. 3-3. doi: 10.24412/2075-4094-2021-1-3-3 (In Russ.)
  6. Andreeva VV, Kuzmina EN. Sovremennyj vzgljad na klassifikaciju rubcovyh deformacij kozhi. Med Tehnologii. Ocenka i Vybor. 2018;(4 (34):83-86. (In Russ.)
  7. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloidsa review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009 Feb;35(2):171-81. doi: 10.1111/j.1524-4725.2008.34406.x
  8. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997 Jun;77(3):701-30. doi: 10.1016/s0039-6109(05)70576-4
  9. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006 Aug;18(4):396-402. doi: 10.1097/01.mop.0000236389.41462.ef
  10. Kljuchareva SV, Nechaeva OS, Kurganskaja IG. Patologicheskie rubcy v praktike dermatokosmetologa: novye vozmozhnosti terapii preparatom Jegallohit (Galaderm). Vestn Jestet Mediciny. 2009;8(2):41-49. (In Russ.)
  11. Marshall CD, Hu MS, Leavitt T, Barnes LA, Lorenz HP, Longaker MT. Cutaneous scarring: basic science, current treatments, and future directions. Adv Wound Care (New Rochelle). 2018 Feb 1;7(2):29-45. doi: 10.1089/wound.2016.0696
  12. Dvorjashina IA, Velikorodnaja JuI, Terentev AV, Zagrebin VL. Jepitelialno-mezenhimalnyj perehod I tipa kak vazhnyj biologicheskij process v jembriogeneze. Vestn VolgVGMU. 2021;78(2):37-45. doi: 10.19163/1994-9480-2021-2(78)-37-45 (In Russ.)
  13. Gröger CJ, Grubinger M, Waldhör T, Vierlinger K, Mikulits W. Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS One. 2012;7(12):e51136. doi: 10.1371/journal.pone.0051136
  14. Arndt KA, red. Korrektsiia rubtsov: per. s angl. Moscow, RF: Prakt Meditsina (Rid Elsiver); 2009. 101p.(In Russ.)
  15. Kogan EA, Andreeva VV, Reshetov IV, Demura TA, Zharkov NV. Morphogenetic and pathogenetic features of hypertrophic and keloid scars of the head and neck. . Arkh Patol. 2022;84(6):23-31. doi: 10.17116/patol20228406123 (In Russ.).
  16. Kogan EA, Andreeva VV, Reshetov IV. Kliniko-morfologicheskie i patogeneticheskie osobennosti keloidnyh rubcov golovy i shei. Head and Neck. Russian Journal. 2022;10(2, Pril.1):50-54. doi: 10.25792/HN.2022.10.2.S1.50-54(In Russ.).
  17. Manturova NE, Stenko AG, Kruglova LS. Rubtsy kozhi klinicheskie proiavleniia diagnostika i lechenie. Moscow, RF: Goetar-Media; 2021. 208 p.(In Russ.)
  18. Taganov AV, Bragina AV. Modem aspects of diagnosis andtreatment. Consilium Medicum. 2021;23(8):637-52. doi: 10.26442/20751753.2021.8.201112 (In Russ.)
  19. Artykov KP, Saidov MS, Muhamadieva KM. Problemy hirurgicheskogo lechenija keloidnyh rubcov kozhi. Vestn Avicenny. 2013;(3):91-94. doi: 10.25005/2074-0581-2013-15-3-91-94 (In Russ.))
  20. Bogachev VYu, Boldin BV, Varich GA. Non-surgical methods for the treatment and . prevention of skin scars.. Outpatient Surgery. 2021;18(2):39-44. doi: 10.21518/1995-1477-2021-18-2-39-44 (In Russ.)
  21. Gaponova AV, Rodin S, Mazina AA, Volchkov PJu.. Epithelial-Mesenchymal Transition: Role in Cancer Progression and the Perspectives of Antitumor Treatment. Acta Naturae. 2020 Jul-Sep;12(3):4-23. doi: 10.32607 (In Russ.)
  22. Volk SW, Iqbal SA, Bayat A. Interactions of the Extracellular Matrix and Progenitor Cells in Cutaneous Wound Healing. Adv Wound Care (New Rochelle). 2013 Jul;2(6):261-72. doi: 10.1089/wound.2012.0417
  23. Yan C, Grimm WA, Garner WL, Qin L, Travis T, Tan N, Han YP. Epithelial to mesenchymal transition in human skin wound healing is induced by tumor necrosis factor-alpha through bone morphogenic protein-2. Am J Pathol. 2010 May;176(5):2247-58. doi: 10.2353/ajpath.2010.090048
  24. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96. doi: 10.1038/nrm3758
  25. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol. 2005 Aug;153(2):295-300. doi: 10.1111/j.1365-2133.2005.06698.x
  26. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007 Mar;127(3):514-25. doi: 10.1038/sj.jid.5700701
  27. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998 Jan;4(1):19-24. doi: 10.1016/S1357-4310(97)80541-2
  28. Greaves NS, Ashcroft KJ, Baguneid M, Bayat A. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci. 2013 Dec;72(3):206-17. doi: 10.1016/j.jdermsci.2013.07.008
  29. Ghahary A, Ghaffari A. Role of keratinocyte-fibroblast cross-talk in development of hypertrophic scar. Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S46-53. doi: 10.1111/j.1524-475X.2007.00225.x
  30. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol. 1996 Mar;106(3):476-81. doi: 10.1111/1523-1747.ep12343658
  31. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol. 2005 Aug;153(2):295-300. doi: 10.1111/j.1365-2133.2005.06698.x
  32. Moyer KE, Saggers GC, Ehrlich HP. Mast cells promote fibroblast populated collagen lattice contraction through gap junction intercellular communication. Wound Repair Regen. 2004 May-Jun;12(3):269-75. doi: 10.1111/j.1067-1927.2004.012310.x
  33. Mukhopadhyay A, Wong MY, Chan SY, Do DV, Khoo A, Ong CT, Cheong HH, Lim IJ, Phan TT. Syndecan-2 and decorin: proteoglycans with a difference--implications in keloid pathogenesis. J Trauma. 2010 Apr;68(4):999-8. doi: 10.1097/TA.0b013e3181c4070d
  34. Linge C, Richardson J, Vigor C, Clayton E, Hardas B, Rolfe K. Hypertrophic scar cells fail to undergo a form of apoptosis specific to contractile collagen-the role of tissue transglutaminase. J Invest Dermatol. 2005 Jul;125(1):72-82. doi: 10.1111/j.0022-202X.2005.23771.x
  35. Köse O, Waseem A. Keloids and hypertrophic scars: are they two different sides of the same coin? Dermatol Surg. 2008 Mar;34(3):336-46. doi: 10.1111/j.1524-4725.2007.34067.x
  36. Greaves NS, Ashcroft KJ, Baguneid M, Bayat A. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci. 2013 Dec;72(3):206-17. doi: 10.1016/j.jdermsci.2013.07.008
  37. Kovaleva LN. Kliniko-morfologicheskie paralleli u pacientov s rubcovoj patologiej kozhi. Dermatovenerologija. Kosmetologija. Seksopatologija. 2016;(1-4):108-17. https://repo.dma.dp.ua/3159/1/13_Kovalyova_34.pdf (In Russ.)
  38. Hawkins HK. Pathophysiology of the burn scar. In: Herndon DN, editor. Total Burn Care. Philadelphia: Saunders Elsevier; 2007. p. 608-19.
  39. Hosper NA, van den Berg PP, de Rond S, Popa ER, Wilmer MJ, Masereeuw R, Bank RA. Epithelial-to-mesenchymal transition in fibrosis: collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition. Exp Cell Res. 2013 Nov 15;319(19):3000-9. doi: 10.1016/j.yexcr.2013.07.014
  40. Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol. 2011 Sep;179(3):1074-80. doi: 10.1016/j.ajpath.2011.06.001
  41. Wermuth PJ, Li Z, Mendoza FA, Jimenez SA. Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1. PLoS One. 2016 Sep 1;11(9):e0161988. doi: 10.1371/journal.pone.0161988. eCollection 2016.
  42. Song S, Zhang R, Cao W, Fang G, Yu Y, Wan Y, Wang C, Li Y, Wang Q. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. J Cell Physiol. 2019 Jun;234(6):9052-64. doi: 10.1002/jcp.27583
Address for correspondence:
246040, Republic of Belarus,
Gomel c., Ilyich str., 290,
State Institution RSPC for Radiation
Medicine and Human Ecology,
Surgical Department,
tel.: 8 0232 389641,
e-mail: yuliyagalitskaya@mail.ru,
Galitskaya Yu. I.
Information about the authors:
Galitskaya Yulia I., Plastic Surgeon of the Surgical Department (Transplantation, Endocrine and Reconstructive Surgery), State Institution RSPC of Radiation Medicine and Human Ecology, Ministry of Health of the Republic of Belarus, Gomel, Republic of Belarus.
https://orcid.org/0009-0004-9883-5731
Achinovich Sergei L., PhD, Head of Pathologoanatomical Department, U Gomel Regional Clinical Oncologic Dispensary, Ministry of Health of the Republic of Belarus, Gomel, Republic of Belarus Ministry of Health of the Republic of Belarus, Gomel, Republic of Belarus.
https://orcid.org/0000-0002-0977-5481
Dundarov Zalimkhan A., MD, Professor, Head the Department of Surgical Diseases No2 Gomel State Medical University, Ministry of Health of the Republic of Belarus, Gomel, Republic of Belarus.
https://orcid.org/0000-0001-8561-691X
Evseenko Dmitry A., PhD, Associate Professor of the Department of Surgical Diseases No2 Gomel State Medical University, Ministry of Health of the Republic of Belarus, Gomel, Republic of Belarus.
https://orcid.org/0000-0002-6835-779X
Contacts | ©Vitebsk State Medical University, 2007-2023